COLUMBUS, OH – July 26, 2019 – In its quest to end cancer, leading non-profit, Pelotonia, today announced a landmark donation to The Ohio State University (OSU) in support of the Pelotonia Institute for ImmunoOncology (PIIO) at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). 

The five-year financial pledge of $102,265,000 is the largest donation in the cancer center’s history. The PIIO will focus exclusively on this innovative area of research that harnesses the body’s immune system to fight cancer and is redefining how cancer is prevented, detected and treated in the United States.

“Conquering cancer is one of the great challenges of our time,” said Doug Ulman, Pelotonia President & CEO and three-time cancer survivor. “With 1.7 million Americans diagnosed with the disease each year, it deserves urgent attention. The recent explosion of discoveries in immuno-oncology have energized this effort and we know that momentum will build exponentially through an even bigger partnership with Ohio State. 

As we open the Pelotonia Institute for Immuno-Oncology – backed by a dedicated community united in our mission, we are entering the next generation of cancer care – a time in which many cancers may become curable.”

The PIIO is made possible by a $102,265,000 gift from Pelotonia. The total amount of the gift – $102,265,000 – is a way of paying tribute to Pelotonia’s inaugural bike ride in 2009 and the 2,265 riders who participated. 

Since then, Pelotonia has grown into a movement that inspires meaningful collective action by mobilizing purpose-driven communities and accelerating funding for innovative cancer research.

For details about how to get involved with Pelotonia, visit www.pelotonia.org. For more information about immuno-oncology research at the OSUCCC – James, visit cancer.osu.edu/PIIO.